Advertisement
News
Advertisement

Biomagnetics Announces Today It Has Entered Into a Licensing Agreement

Tue, 03/13/2012 - 5:45am
The Associated Press

SAN FRANCISCO--(BUSINESS WIRE)--Mar 13, 2012-- Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the Company has signed an agreement to sell the Company's interest in the Chinese biodegradable plastic to Global Bio Energy Corp.

Biomagnetics entered into an agreement with Global Bio Energy Corp.

The terms of the agreement are as follows; a $50,000 non-refundable deposit upon signing, $1,000,000 dollars cash on closing, four quarterly payments of $250,000 dollars and five million shares of common stock in Global Bio Energy Corp.

Mr. Hardman continues, "Our progress with the Chinese programs was delayed by the unexpected death of our point man in China. It then became necessary to build direct personal business relationships. The results of my recent trip show this effort has been successful." About Biomagnetics Diagnostics Corp.

Biomagnetics Diagnostics Corporation is an advanced medical device and Biotechnology Company and an acquirer of other innovative technologies. The Company is currently developing a waveguide-based advanced integrated optical biosensor through its cooperative research and development agreement with Los Alamos National Security, LLC, which will initially be used for cholera, tuberculosis and malaria diagnosis. More information on Biomagnetics Diagnostics Corp. can be seen at www.biomagneticsbmgp.com.

CONTACT: Biomagnetics Diagnostics Paul Hardman, 916-987-7078 KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: HEALTH AIDS BIOTECHNOLOGY INFECTIOUS DISEASES MEDICAL DEVICES RESEARCH SCIENCE SOURCE: Biomagnetics Diagnostics Copyright Business Wire 2012 PUB: 03/13/2012 09:00 AM/DISC: 03/13/2012 09:00 AM http://www.businesswire.com/news/home/20120313005651/

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading